Heart failure & cardiomyopathies
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction
Pooled resultResult — go to the resultHazard ratio 0.75 95% CI 0.57–0.99Authors' conclusion
Management of patients with HFrEF using an implantable hemodynamic monitor significantly reduces both mortality and HF hospitalizations. The reduction in HF hospitalizations is seen early in the first year of monitoring and mortality benefits occur after the first year.
Study context
- Population
- Patients with heart failure and reduced ejection fraction (HFrEF)
- Participants
- 1,350 patients3 RCTs
- Comparison
- Hemodynamic-monitoring guided management vs control
- Outcome
- All-cause mortality and heart failure (HF) hospitalizations
Pooled result
As reported in the abstract
Hazard ratio
0.75
95% CI 0.57–0.99
P = 0.043
Hemodynamic-monitoring guided managementvs control
HR 0.75 (95% CI 0.57–0.99); P = 0.043
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. Published 13 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →